This antagonistic relationship between the actions of group 1 mGluRs and FMRP on mRNA translation led to the proposal that inhibiting group 1 mGluR signaling might counter the effect of reduced FMRP function in patients with fragile X syndrome, and ameliorate some of the associated symptoms80. The gene discussed is FMR1; the disease is fragile X syndrome.